Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 42

Trial Status

Completed2
Other1

Role Distribution

Principal Investigator3
PI Rate100%

Activity Timeline

Clinical Trials (3)

NCT02584140Phase 4Completed
Pre-exposure Prophylaxis (PrEP) Adherence Enhancement Guided by iTAB and Drug Levels for Women
HIV Prevention
PrincipalinvestigatorStart date: 2016-05-01
NCT02390297Active Not Recruiting
Long Term Follow up for the Detection of Delayed Adverse Events in Cal-1 Recipients
HIV-1 InfectionReceipt of Cal-1 Modified Hematopoietic Cellular Products
PrincipalinvestigatorStart date: 2015-04-01

Research Network

Collaboration Network

2 collaborators·1 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

University of California, Los Angeles

Similar Key Opinion Leaders

Publications (0)

No publications found for this investigator.

Clinical Trials (3)

Showing 3 of 3 trials

NCT02584140Phase 4PrincipalInvestigator

Pre-exposure Prophylaxis (PrEP) Adherence Enhancement Guided by iTAB and Drug Levels for Women

HIV Prevention
Completed
NCT02390297PrincipalInvestigator

Long Term Follow up for the Detection of Delayed Adverse Events in Cal-1 Recipients

HIV-1 InfectionReceipt of Cal-1 Modified Hematopoietic Cellular Products
Active Not Recruiting
NCT01781806Phase 4PrincipalInvestigator

A Demonstration Project to Add Pre- or Post-exposure Prophylaxis to Combination HIV Prevention Services

HIV Prevention
Completed

All 3 trials loaded